Yiben Health Files IPO Prospectus: Redefining Respiratory Care with AI-Driven Chronic Disease Management
Yiben Huxi is the first mobile health product launched by Hangzhou Yiben Health Technology Co., Ltd. It focuses on respiratory care and is positioned as a tool-based medical service platform. In response to the broader trends of change in the healthcare landscape, Yiben Health analyzes user needs and identifies diseases that can be better controlled and managed through “Internet Plus” solutions.(abbreviated as specialized disease). It redefines medical services, with the main product application threads being convenient doctor-patient connectivity, out-of-hospital disease management, and the reconstruction of healthcare professionals’ value; it centers on intelligent disease-specific management as the core of product development, meeting users’ growing demands for health and medical services.
The Yiben Huxi App is available in two versions: a public version and a physician version. It offers a range of services, including online consultations, specialized disease management, second opinions, physician team collaboration, patient education, and medical news. In response to the increasingly severe smog conditions in recent years, it has also launched the Yiben Index service for its users.
The Yiben Index model, which predicts the incidence of respiratory diseases associated with external environmental factors such as weather, has been endorsed by the China Meteorological Administration, leading to an initial collaboration.
In recent years, cities across China have been increasingly engulfed by smog, with conditions worsening significantly during the winter months. Many urban areas resemble smoking lounges, shrouded in thick haze. In an interview with CCTV, Academician Zhong Nanshan of the Chinese Academy of Engineering stated that air pollution is far more alarming than SARS; while SARS patients can be isolated, no one can escape exposure to polluted air. Relevant studies have also confirmed that smoggy weather can trigger or exacerbate respiratory diseases. Although there are no immediate, effective strategies to eliminate smog, we can take measures to mitigate its harmful effects on human health. In response, YiBen Health has launched the "YiBen Index." This system collects real-time data on environmental factors and respiratory disease-related indices based on changing weather conditions, performs backend computational analysis, and pushes personalized disease risk assessments to users according to their individual health profiles, thereby enabling timely preventive care.
The First Product on the Entire Internet to Apply Models and Algorithms for Intelligent Asthma Management
The YiBenHuxi App’s first disease-specific intelligent management product, “XiaoNing” (English name: Fit-PEF), reduces the risk of asthma recurrence and exacerbation through intelligent, personalized management, thereby achieving effective disease and cost control while improving patients’ quality of life. Leveraging an intelligent decision-support system and medical big data, it enhances physicians’ work efficiency and accumulates case records and data to provide professional support for disease management and clinical medical research, filling the gap in out-of-hospital asthma management within the current healthcare system.
Xiaoning is a mobile-based disease management tool for asthma patients and physicians. By leveraging data collected from mobile devices and applying the Yiben Asthma-Specific Disease Management Model, its core algorithms generate asthma-related metrics and visualizations, provide disease assessments and early warnings, and establish a mechanism for out-of-hospital self-management by patients coupled with timely clinical intervention by physicians, thereby achieving the dual goals of improved disease control and cost containment.
Pediatric Asthma Relief: Deepening Personalized Customization for Specific Diseases
In the healthcare sector, given that each individual’s physical constitution and clinical condition are unique, one-on-one personalized service plans are essential to delivering an optimal patient experience. This principle equally applies to asthma management. Asthma is categorized into adult asthma and pediatric asthma, which require substantially different management models. In response to these disease-specific personalized needs, and following the launch of its out-of-hospital management program for adult asthma, YiBen HuXi will simultaneously introduce a dedicated out-of-hospital management tool designed specifically for pediatric asthma.
The design and optimization of the Yiben disease-specific management model and its core algorithms have received support from the Guangzhou Institute of Respiratory Diseases, the Zhejiang University Institute of Respiratory Diseases, and numerous top-tier experts. The Yiben Asthma Index, a model that leverages disease data to predict acute asthma exacerbations, has gained recognition from Paul O’Byrne, former Chair of the Global Initiative for Asthma (GINA), leading to an intention to collaborate.
Hangzhou Yiben Health: Internet + Intelligent Disease-Specific Management
Hangzhou Yiben Health Technology Co., Ltd. was established in January 2015. Guided by the philosophy of “Convenient Medical Care, Intelligent Treatment,” the company is committed to integrating mobile internet and artificial intelligence with current medical practices, providing innovative mobile healthcare service tools and platforms for physicians and the general public.
Leveraging the Yiben Intelligent Cloud, the company will gradually develop unique core competencies in intelligent disease-specific management through continuous optimization of Yiben’s disease-specific management model algorithms and the application of smart hardware, thereby building an industrial ecosystem centered on “Internet Plus” intelligent disease-specific management.
Yiben Respiratory Core Team
The Yiben Cloud R&D team is guided by Ph.D. holders in Computer Science and Technology for model development, optimization, and research.
CEO Liu Jidong
Former Vice President of Shenzhen INVT Electric Co., Ltd. (Stock Code: 002334); Founder of Hangzhou Beilaifu Investment Co., Ltd. Possesses extensive experience in corporate management and market operations.
Chief Medical OfficerHu Xuanyi
Graduated from Fudan University Medical School (formerly Shanghai First Medical College) in 1990; Visiting Scholar at the Heart Hospital, University of London; Chief Physician and Professor of Cardiovascular Surgery.
CTO Zhang Youqun
A senior wireless expert at Alibaba, he once led the technical team for Alibaba’s SNS application “Laiwang” and later served as the technical lead for Alibaba Cloud’s wireless development platform, possessing extensive experience in mobile internet research, development, and implementation.
Product ManagerHu Ruofei
Ph.D. Candidate in Telemedicine and Biomedical Engineering, Universidad Politécnica de Madrid. Conducted four years of research on intelligent management of chronic diseases at the LifeStech Laboratory. Participated in the management of the METABO and No One Left Behind projects under the EU’s FP7 Programme.
By Li Xiaoguo (This article is a guest contribution)
Finally, startup teams seeking media coverage are welcome to contact us at:tg@vcbeat.top。